The Department of Health and Human Services plans to implement a long-delayed 340B rule that would set price caps and monetary penalties in the 340B program, FierceHealthcare reports.
According to the report, HHS issued a notice, saying the rule would be implemented at the start of the year on Jan. 1.
The rule, which has been frequently delayed by the Trump administration, would ultimately implement price ceilings and penalize pharmaceutical companies engaged in deliberate overcharging of 340B hospitals.
“These rules were ordered by Congress more than eight years ago based on clear, documented evidence of overcharging by drug companies of 340B hospitals, clinics and health centers,” 340B interim CEO Maureen Testoni said. “The time for delay is over and now it is time for action.”